Glyphic Biotechnologies is building a first-of-its-kind Next Generation Protein Sequencing platform capable of distinguishing all 20 canonical amino acids and post-translational modifications. We believe our technology will bring about an Illumina-like revolution in proteomics -- "Illumina-like" both in its ability to define a new era of biological discovery and to expand and create new markets. We are at an important moment in our team's evolution. We are currently hiring for 3 important roles (with more on the way in Q2). If you're interested in any of the below, please apply or contact me directly to discuss. 🗄️ Associate, Operations: https://lnkd.in/gqyC_jkh 👾 Senior/Staff Scientist, Bioinformatics: https://lnkd.in/gDpS9MdT ⚙️ Staff/Principal Engineer, Fluidics: https://lnkd.in/gb67q7Xz
Glyphic Biotechnologies
Biotechnology Research
Berkeley, CA 3,438 followers
Next Generation Protein Sequencing.
About us
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.
- Website
-
http://www.glyphic.bio/
External link for Glyphic Biotechnologies
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Berkeley, CA
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Proteomics, Protein Sequencing, NGPS, Life Sciences, and Biotechnology
Locations
-
Primary
Berkeley, CA, US
-
New York City, New York, US
Employees at Glyphic Biotechnologies
-
Craig Asher
Managing Director at OMX Ventures
-
Helen H. Liang, PhD
Founder & Managing Partner of FoundersX Ventures. Featured on WSJ and Business Insider as a Pioneering Tech VC. Board Director. Invited Speaker at…
-
Yinghua Sun
SVP of Product Development
-
Mike Lucero
Life Science Tools Executive